pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - agenți antineoplazici - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.
bonefos 800 mg
bayer oy - finlanda - acid clodronicum - compr. film. - 800mg - med. ce influenteaza structura osoasa si mineralizarea bifosfonati
sindronat 300 mg/5 ml
sindan pharma s.r.l. - romania - acid clodronicum - conc. pt. sol. perf. - 300mg/5ml - med. ce influenteaza structura osoasa si mineralizarea bifosfonati
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - agenți antineoplazici - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
sorbifer durules 320 mg + 60 mg comprimate filmate
egis pharmaceuticals plc - ferrosi sulfas + acid ascorbicum - comprimate filmate - 320 mg + 60 mg
corvalfen picaturi orale, solutie
beta srl - o combinatie - picaturi orale, solutie
cupidon-farm comprimate 35 mg
farmaco sa, im - sildenafilum - comprimate - 35 mg
cupidon-farm comprimate 70 mg
farmaco sa, im - sildenafilum - comprimate - 70 mg
drotaverin comprimate 40 mg
lekpharm srl - drotaverinum - comprimate - 40 mg
amlodipin comprimate 5 mg
lekpharm srl - amlodipinum - comprimate - 5 mg